{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:31:37Z","timestamp":1787725897326,"version":"build-2784847793"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore clinical and ultrasonographic features preceding the development of a difficult-to-treat (D2T) phenotype in a real-world cohort of patients with psoriatic arthritis (PsA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, consecutive PsA patients (January 2020-September 2024) were included. D2T PsA was defined according to a pragmatic operational definition based on persistent disease activity despite \u22652 biologic or targeted synthetic disease-modifying antirheumatic drugs (b\/tsDMARDs). Baseline demographic and clinical data were collected. Ultrasound (US) assessment included synovitis, erosions, tenosynovitis, enthesitis, bursitis, and dactylitis, using approved definitions and scoring systems. Predictors of D2T were analyzed using Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 152 patients were included (81 D2T, 71 non-D2T), with US data available in 117. D2T patients were younger at diagnosis (47.3\u00a0\u00b1\u00a011.4 vs 53.2\u00a0\u00b1\u00a010.1 years, p&amp;lt;0.001). In the overall multivariable Cox model, no baseline clinical variable independently predicted D2T. However, when diagnostic delay was categorized using a \u22651-year threshold, Kaplan-Meier analysis showed reduced D2T-free survival in patients with diagnostic delay \u22651 year (log-rank p=0.025). When analyses were stratified according to predominant disease pattern, diagnostic delay \u22651 year remained independently associated with D2T in both peripheral [HR 1.74 (95% CI 1.05\u20132.88), p=0.032] and axial PsA [HR 3.18 (1.22\u20138.27), p=0.018]. In axial disease, fibromyalgia [HR 2.45 (1.12\u20135.36), p=0.025] and enthesitis [HR 2.49 (1.08\u20135.70), p=0.033] were additional predictors. In multivariable Cox regression, higher mean bilateral Global OMERACT\/EULAR US Synovitis Score (GLOESS) at the first metatarsophalangeal joint (MTP) was directly associated [HR 3.21 (1.47\u20136.99), p=0.003] while mean GLOESS at the wrist was inversely [HR 0.52 (0.33\u20130.80), p=0.003] associated with D2T.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this retrospective exploratory cohort, diagnostic delay of at least one year and selected US features were associated with later D2T PsA classification. First MTP GLOESS was positively associated with D2T classification, whereas wrist GLOESS showed an inverse association. These findings should be interpreted cautiously because of the retrospective design, variable US timing, and need for external validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1869052","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:08:21Z","timestamp":1787724501000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and ultrasonographic features preceding a difficult-to-treat phenotype in psoriatic arthritis: a retrospective real-world exploratory cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Elisa","family":"Bellis","sequence":"first","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariele","family":"Gatto","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cruciani","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Favaro","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Croce","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]},{"name":"Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale UPO","place":["Novara, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Luppi","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Agugliaro","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Garulli","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Laterza","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Crepaldi","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Data","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lomater","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Saracco","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Iagnocco","sequence":"additional","affiliation":[{"name":"Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, Mauriziano Hospital","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01083-y","article-title":"Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow","volume":"20","author":"Siebert","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/pqpzef","article-title":"Potential difficult-to-treat psoriatic arthritis real-world prevalence and contributing factors","volume":"43","author":"Alp","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ard.2025.10.002","article-title":"EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis","volume":"85","author":"Marzo-Ortega","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01329-3","article-title":"Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative","volume":"22","author":"Proft","year":"2026","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1509082","article-title":"Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort","volume":"11","author":"Favalli","year":"2024","journal-title":"Front Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.42780","article-title":"Difficult-to-treat psoriatic arthritis: a conceptual approach","volume":"76","author":"Fagni","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225087","article-title":"Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey","volume":"83","author":"Marzo-Ortega","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2025.05.003","article-title":"Practical guide for the use of ultrasound in psoriasis and psoriatic arthritis","volume":"51","author":"Mehta","year":"2025","journal-title":"Rheum Dis Clin N Am"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2025.105949","article-title":"Understanding difficult-to-treat psoriatic arthritis: data from the rheumatic diseases Portuguese registry","volume":"93","author":"Abreu","year":"2026","journal-title":"Joint Bone Spine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2025-005717","article-title":"Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still Undefined subset of patients","volume":"11","author":"Currado","year":"2025","journal-title":"RMD Open"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-022-00461-w","article-title":"Clinical characteristics of potential difficult-to-treat patients with psoriatic arthritis: a retrospective analysis of a longitudinal cohort","volume":"9","author":"Perrotta","year":"2022","journal-title":"Rheumatol Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152275","article-title":"Characteristics of difficult-to-treat psoriatic arthritis: a comparative analysis","volume":"63","author":"Philippoteaux","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae263","article-title":"Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry","volume":"63","author":"Vassilakis","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181385","article-title":"Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound, and clinical outcomes: data from the TICOPA trial","volume":"47","author":"Helliwell","year":"2020","journal-title":"J Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2018.10.008","article-title":"AAPT diagnostic criteria for fibromyalgia","volume":"20","author":"Arnold","year":"2019","journal-title":"J Pain"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108217","article-title":"The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.2.148","article-title":"Development of a disease activity index for the assessment of reactive arthritis (DAREA)","volume":"39","author":"Eberl","year":"2000","journal-title":"Rheumatology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211585","article-title":"The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology","volume":"76","author":"M\u00f6ller","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181095","article-title":"OMERACT definitions for ultrasonographic pathologies and elementary lesions of rheumatic disorders 15 years on","volume":"46","author":"Bruyn","year":"2019","journal-title":"J Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000428","article-title":"Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce\u2014part 1: definition and development of a standardised, consensus-based scoring system","volume":"3","author":"D\u2019Agostino","year":"2017","journal-title":"RMD Open"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217191","article-title":"Novel and reliable dactylitis global sonographic (DACTOS) score in psoriatic arthritis","volume":"79","author":"Zabotti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213609","article-title":"Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative","volume":"77","author":"Balint","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000427","article-title":"Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce\u2014part 2: reliability and application to multiple joints of a standardised consensus-based scoring system","volume":"3","author":"Terslev","year":"2017","journal-title":"RMD Open"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab628","article-title":"Response to secukinumab on synovitis using power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE","volume":"61","author":"D\u2019Agostino","year":"2022","journal-title":"Rheumatology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152259","article-title":"Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension","volume":"63","author":"D\u2019Agostino","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05722-1","article-title":"Biological therapy for psoriatic arthritis: current state and future perspectives","volume":"44","author":"Boboryko","year":"2024","journal-title":"Rheumatol Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003809","article-title":"Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project","volume":"10","author":"Singla","year":"2024","journal-title":"RMD Open"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150938","article-title":"Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease","volume":"70","author":"Gladman","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201972","article-title":"Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish early psoriatic arthritis register (SwePsA)","volume":"73","author":"Theander","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-004062","article-title":"Window of opportunity in psoriatic arthritis: the earlier the better","volume":"10","author":"Snoeck Henkemans","year":"2024","journal-title":"RMD Open"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15091125","article-title":"Increased musculoskeletal surgery rates during diagnostic delay in psoriatic arthritis: a retrospective cohort study","volume":"15","author":"Yolbas","year":"2025","journal-title":"Diagnostics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224148","article-title":"EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis","volume":"82","author":"Zabotti","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220562","article-title":"Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia","volume":"80","author":"Polachek","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07267-x","article-title":"Refractory psoriatic arthritis: emerging concepts in whole process management","volume":"44","author":"Xu","year":"2025","journal-title":"Clin Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151491","article-title":"The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study","volume":"43","author":"Brikman","year":"2016","journal-title":"J Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003995","article-title":"Association between musculoskeletal sonographic features and response to treatment in patients with psoriatic arthritis","volume":"10","author":"Gutierrez","year":"2024","journal-title":"RMD Open"},{"key":"B40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3899\/jrheum.2023-0091","article-title":"Ultrasound in the management of patients with psoriatic arthritis: systematic literature review and novel algorithms for pragmatic use","volume":"51","author":"Gouze","year":"2024","journal-title":"J Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021942","article-title":"Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (ultrasound in psoriatic arthritis treatment) prospective observational study protocol","volume":"8","author":"Canzoni","year":"2018","journal-title":"BMJ Open"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000765","article-title":"DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs","volume":"4","author":"Puk\u0161i\u0107","year":"2018","journal-title":"RMD Open"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203073","article-title":"Disparity between ultrasound and clinical findings in psoriatic arthritis","volume":"73","author":"Husic","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-04981-0","article-title":"At the crossroads of gout and psoriatic arthritis: \u201cpsout","volume":"39","author":"Felten","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/rheumatology\/keu328","article-title":"Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era","volume":"54","author":"McGonagle","year":"2015","journal-title":"Rheumatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869052\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:08:22Z","timestamp":1787724502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869052\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2026.1869052"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1869052","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1869052"}}